000 01176 a2200313 4500
005 20250515071621.0
264 0 _c20070925
008 200709s 0 0 eng d
022 _a1359-4184
024 7 _a10.1038/sj.mp.4002009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArranz, M J
245 0 0 _aPharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
_h[electronic resource]
260 _bMolecular psychiatry
_cAug 2007
300 _a707-47 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntipsychotic Agents
_xpharmacokinetics
650 0 4 _aBlood-Brain Barrier
_xdrug effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aCytochrome P-450 Enzyme System
_xgenetics
650 0 4 _aDrug Interactions
_xgenetics
650 0 4 _aHumans
650 0 4 _aNeurotransmitter Agents
_xmetabolism
650 0 4 _aPharmacogenetics
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _ade Leon, J
773 0 _tMolecular psychiatry
_gvol. 12
_gno. 8
_gp. 707-47
856 4 0 _uhttps://doi.org/10.1038/sj.mp.4002009
_zAvailable from publisher's website
999 _c17088339
_d17088339